{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:29:16Z","timestamp":1793852956550,"version":"4.6.1"},"reference-count":22,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shandong Yeedo Biotechnology Co., Ltd"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/21645515.2024.2426289","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T12:26:20Z","timestamp":1731500780000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-5439","authenticated-orcid":false,"given":"Jia","family":"Li","sequence":"first","affiliation":[{"name":"National Institute for Food and Drug Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Shandong Yeedo Biotechnology Co Ltd","place":["Dongying, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6471-1285","authenticated-orcid":false,"given":"Xiaohong","family":"Wu","sequence":"additional","affiliation":[{"name":"National Institute for Food and Drug Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Wang","sequence":"additional","affiliation":[{"name":"National Institute for Food and Drug Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-8855","authenticated-orcid":false,"given":"Leitai","family":"Shi","sequence":"additional","affiliation":[{"name":"National Institute for Food and Drug Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhua","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Institute for Food and Drug Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9854-9663","authenticated-orcid":false,"given":"Haiyan","family":"Liang","sequence":"additional","affiliation":[{"name":"Shandong Yeedo Biotechnology Co Ltd","place":["Dongying, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Mo","sequence":"additional","affiliation":[{"name":"Guangxi Zhuang Autonomous Region Center For Disease Control and Prevention","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-260X","authenticated-orcid":false,"given":"Shouchun","family":"Cao","sequence":"additional","affiliation":[{"name":"National Institute for Food and Drug Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"World Health Organization. WHO expert consultation on rabies [Third report]. WHO technical report series no. 1012. Geneva Switzerland: World Health Organization; 2018."},{"issue":"3","key":"e_1_3_4_3_1","first-page":"161","article-title":"Technical guidelines for human rabies prevention and control","volume":"6","author":"Chinese Center for Disease Control and Prevention","year":"2016","unstructured":"Chinese Center for Disease Control and Prevention. Technical guidelines for human rabies prevention and control. Chin J Viral Dis. 2016;6(3):161\u20139.","journal-title":"Chin J Viral Dis"},{"key":"e_1_3_4_4_1","unstructured":"WHO Expert Committee on Rabies. Guide for post-exposure treatment [Eighth report]. WHO technical report 824. Geneva Switzerland: World Health Organization; 1992."},{"key":"e_1_3_4_5_1","first-page":"327","article-title":"Adverse reaction and immune effect of domestic adjuvant-free rabies vaccine prepared with vero cells","volume":"21","author":"Huazhuang L","year":"2008","unstructured":"Huazhuang L, Guihua H, Qing C, Huai P. Adverse reaction and immune effect of domestic adjuvant-free rabies vaccine prepared with vero cells. Chin J Biol. 2008;21:327\u2013328.","journal-title":"Chin J Biol"},{"key":"e_1_3_4_6_1","first-page":"206","article-title":"Safety and immune effect of adjuvant-free rabies vaccine","volume":"19","author":"Li Z","year":"2006","unstructured":"Li Z, Jun G, Jianying H, Zhumu B, Deming Y. Safety and immune effect of adjuvant-free rabies vaccine. Chin J Biol. 2006;19:206\u2013207.","journal-title":"Chin J Biol"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.4161\/21645515.2014.972773"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.4161\/21645515.2014.995059"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.4161\/21645515.2014.994460"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1279770"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20985"},{"key":"e_1_3_4_12_1","unstructured":"National Medical Products Administration. Guiding principles for adverse event grading standards in clinical trials of prophylactic vaccines. https:\/\/clinregs.niaid.nih.gov\/sites\/default\/files\/documents\/china\/NMPA-No102-2019_Google-Translation.pdf."},{"issue":"3","key":"e_1_3_4_13_1","first-page":"1","article-title":"Human rabies prevention\u2013United States, 2008: recommendations of the advisory committee on immunization practices","volume":"57","author":"Manning SE","year":"2008","unstructured":"Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, et al. Human rabies prevention\u2013United States, 2008: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2008 May 23;57(RR\u20133):1\u201328. PMID: 18496505.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-1157(79)80024-4"},{"key":"e_1_3_4_15_1","unstructured":"World Health Organization WHO Expert Consultation on Rabies. Second report. World Health Organ tech Rep Ser. 2013:1\u2013139. back cover."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2027714"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.06.035"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2211896"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1778408"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.28420"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1473765"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1230260"},{"issue":"2","key":"e_1_3_4_23_1","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht CE","year":"2010","unstructured":"Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett SM, Levis R, Meltzer MI, Schaffner W, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2010 Mar 19;59(RR\u20132):1\u20139. Erratum in: MMWR Recomm Rep 2010 Apr 30; 59(RR\u20132):1\u20139. PMID: 20300058.","journal-title":"MMWR Recomm Rep"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2426289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T16:51:48Z","timestamp":1744649508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2426289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2426289"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2426289","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2426289"}}